(Q37570954)

21 August 2017

1 reference

title

Evolution of prophylaxis: MoAb, siRNA, vaccine, and small molecules (English)

1 reference

21 August 2017

Octavio Ramilo

1

1 reference

21 August 2017

1 June 2009

1 reference

Paediatric Respiratory Reviews

21 August 2017

1 reference

21 August 2017

10 Suppl 1

1 reference

21 August 2017

23-25

1 reference

Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. The PREVENT Study Group

21 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2809%2970011-9

7 January 2021

Comparative effects of two neutralizing anti-respiratory syncytial virus (RSV) monoclonal antibodies in the RSV murine model: time versus potency

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2809%2970011-9

7 January 2021

Inhibition of respiratory viruses by nasally administered siRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2809%2970011-9

7 January 2021

Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2809%2970011-9

7 January 2021

Safety and pharmacokinetics of palivizumab therapy in children hospitalized with respiratory syncytial virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2809%2970011-9

7 January 2021

Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2809%2970011-9

7 January 2021

Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2809%2970011-9

7 January 2021

Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2809%2970011-9

7 January 2021

10.1016/S1526-0542(09)70011-9

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

19651397